Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate.
about
Inhaled corticosteroids for cystic fibrosisInhaled corticosteroids for cystic fibrosisInhaled corticosteroids for cystic fibrosisThe use of inhaled corticosteroids in pediatric asthma: updateTreatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical ImmThe Saudi Initiative for Asthma.Asthma and other recurrent wheezing disorders in children (chronic)Survey of adrenal crisis associated with inhaled corticosteroids in the United KingdomInhaled corticosteroids in childhood asthma: the story continuesInhaled corticosteroids and secondary adrenal insufficiencyAdrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy.Systematic review of the dose-response relation of inhaled fluticasone propionate.Decreased cortisol response to insulin induced hypoglycaemia in asthmatics treated with inhaled fluticasone propionate.Monitoring growth in asthmatic children treated with high dose inhaled glucocorticoids does not predict adrenal suppression.The effect of asthma and its treatment on growth.Fluticasone propionate in asthma: a long term dose comparison study.Prescribed doses of inhaled steroids in Dutch children: too little or too much, for too short a time.Transient symptomatic hyperglycaemia secondary to inhaled fluticasone propionate in a young child.Oral and inhaled corticosteroids and adrenal insufficiency: a case-control studyUpdate in pediatric lung disease 2008.Moderate dose inhaled corticosteroid-induced symptomatic adrenal suppression: case report and review of the literature.Intermittent steroid inhalation for the treatment of childhood asthma.Inhaled corticosteroids and HPA axis suppression: how important is it and how should it be managed?Co-administration of salbutamol and fluticasone for emergency treatment of children with moderate acute asthma.Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone.Lost in the mist: acute adrenal crisis following intranasal fluticasone propionate overuse.High-dose inhaled corticosteroid use in childhood asthma: an observational study of GP prescribing.Acute adrenal crisis in an asthmatic child treated with inhaled fluticasone proprionatePrevalence of hypothalamic-pituitary-adrenal axis suppression in children treated for asthma with inhaled corticosteroid.Adrenal insufficiency after treatment with fluticasone. Second line controller treatment might have been triedGrowth and adrenal suppression due to moderate- to high-dose inhaled fluticasone.Recovery of hypothalamo-pituitary-adrenal axis suppression during treatment with inhaled corticosteroids for childhood asthma.Early morning salivary cortisol and cortisone, and adrenal responses to a simplified low-dose short Synacthen test in children with asthma.Fatal and near-fatal encephalopathy with hyponatraemia in two siblings with fluticasone-induced adrenal suppression.Adrenal function improves in asthmatic children on inhaled steroids: a longitudinal study.Inhaled corticosteroids for cystic fibrosisPredictors for failed dose reduction of inhaled corticosteroids in childhood asthma
P2860
Q24193120-B956A504-A84C-4ECF-84A2-B1A502E6A176Q24202923-0BEEEB79-4EC7-4DB1-8E29-53771672B601Q24241634-F1327D94-6AFE-4BE1-ACF5-4309678C984EQ26739763-5303CCA7-0326-4A93-A75E-0A958B2445FBQ28275393-55CBF26F-A6DE-4009-9303-D5C2EC622D56Q33568644-C8CC3FBE-0C74-439D-8780-9B3FD672741CQ34150855-66A42036-3632-49D8-88CD-C1BB4195D61BQ34161394-BD9D15BC-6B8C-46ED-9C17-361549140D66Q34995731-E756EC3D-8C66-4CE6-A2D5-DA90BDF3DAB6Q35056188-F0B3C1A2-5878-4369-9DF6-62BFC133084EQ35225926-EB8DE076-7151-42BC-8CFC-CBD0814FFB47Q35277117-0795CD22-680C-46C3-8EEF-C2B14F0D191CQ35277394-C899D6E9-3326-48EE-A3F1-A3F8E0CB06B0Q35280467-85427359-7762-4A72-B718-0A8AD405B89FQ35556289-67F62D2E-FBAF-4633-BB87-33D50EE58590Q35571425-E1098BD3-4FEC-474A-B898-043284CDCB42Q35827836-10C837FF-898F-415F-81E6-F02CBC3004DDQ35892139-50753445-0C6F-4FDE-A8EC-F36391598D6BQ36203058-C699D9E4-96AD-480F-9BC7-9DEFCA075627Q37436769-AB9607A8-2AC9-48F7-B63B-A3FA21529517Q38050146-00902112-A4FA-4211-B609-1B96B8CD853FQ38631599-6512EF6C-D3B3-498E-ACB9-B462C8B12DF6Q38796254-46904F5A-FCDC-4204-BBE9-F2ADA9B8E37CQ39360302-44929DBB-9D20-4611-AEB4-E2496F692907Q39783136-01544881-C312-4379-AAB8-55BDC3DA792DQ40347936-B9F45A4C-C8A4-4504-8D36-7FFFD411C1A6Q41775559-CCDEA8FA-0CCD-44AA-9EF4-AED64EDB517DQ42205901-A57CE0AF-A670-49EA-8FD8-BC87C24109A4Q42210320-B8C5F8DF-787F-4638-9028-B183C8AAF8DAQ42247654-1CF17A66-5395-4693-86B1-4B940ACB7F6EQ44201242-812085DB-6391-4FCC-A2F6-EDCE86C4C43DQ47094015-1C42CF44-1895-4122-A31B-B39A0584B8E3Q47911239-940B8539-B574-4FEA-955C-B7C131DA177EQ48233429-AEB3C9AD-9C99-4DD8-90D7-1D49F7790EF8Q48463575-B7BC3E4A-18FB-4D3F-9384-B2FC82ED06C7Q56084189-DBEFA46D-0358-4CD1-9AB1-ADE49333B9FEQ58811404-6324AA02-5282-41AA-AA0C-0ABDAE8348FD
P2860
Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Symptomatic adrenal insufficie ...... nhaled fluticasone propionate.
@en
Symptomatic adrenal insufficie ...... nhaled fluticasone propionate.
@nl
type
label
Symptomatic adrenal insufficie ...... nhaled fluticasone propionate.
@en
Symptomatic adrenal insufficie ...... nhaled fluticasone propionate.
@nl
prefLabel
Symptomatic adrenal insufficie ...... nhaled fluticasone propionate.
@en
Symptomatic adrenal insufficie ...... nhaled fluticasone propionate.
@nl
P2093
P2860
P1433
P1476
Symptomatic adrenal insufficie ...... nhaled fluticasone propionate.
@en
P2093
A Prendiville
E C Crowne
J P H Shield
R J Howells
P2860
P304
P356
10.1136/BMJ.324.7345.1081
P407
P577
2002-05-01T00:00:00Z